It is important to remember that you are not alone. In the U.S. there are over 600,000 hysterectomies performed each year, about 1,643 a day.
It is important to remember that you are not alone. In the U.S. there are over 600,000 hysterectomies performed each year, about 1,643 a day. In fact, by the age of 60, 1 in 3 women will have had a hysterectomy. This site is intended to provide you with facts so you can make an informed decision with your health care provider about your choices.
Today's hysterectomy choices include innovative, minimally-invasive procedures that can be modified by your doctor to address the treatment and relief of your symptoms. These new advanced surgical techniques reduce the pain and minimize the scarring from surgery, typically require only one day in the hospital, and get you back to your normal routine in less than a week on average. Click on Hysterectomy Options for more information.
Hysterectomy Quick Facts
Sources
1. Hoffman C, Kennedy J, Borschel L, Burchette R, Kidd A. Laparoscopic Hysterectomy: The Kaiser Permanente San Diego experience. Journal of Minimally Invasive Gynecology 2005;12:16-24.
Important Note to Reader: The information in these Web pages is for your general knowledge and background only. Note that these Web pages contain information from various sources considered to be dependable. However, we make no representations, warranties or other expressed or implied warranties or guarantees regarding the accuracy, reliability or completeness of the information. Under no circumstance shall Gyrus ACMI, Inc., Olympus America Inc. and/or its or their respective affiliates, employees, consultants, agents or representatives (collectively "Gyrus") be liable for any costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be in incurred in connection with the information provided or any use thereof.
© 2010 Gyrus ACMI, Inc. All rights reserved. | Privacy Policy | Legal Notice
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More